dr. ai on the use of hypomethylating agents in patients with mds
Published 6 years ago • 3.9K plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:03
dr. ai on single-agent and combination therapy in patients with mds
-
3:46
hypomethylating agents in the treatment of high-risk mds
-
6:57
hypomethylating agents in mds: factors to consider
-
3:58
hypomethylating agents in low-risk mds
-
5:53
defining and predicting response to hypomethylating agents in myelodysplastic syndrome
-
3:40
hypomethylating agents for aml
-
1:05
dr. ai on the fda approval of mogamulizumab in ctcl
-
6:47
treatment of myelodysplastic syndromes refractory to hypomethylating agent
-
20:13
debate: hypomethylating agents are appropriate in lower-risk mds - only use with caution
-
4:48
hypomethylating agents in mds management
-
1:12
hypomethylating agents for low risk mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
5:47
using computational algorithms to predict the response of mds patients to hypomethylating agents
-
17:34
how machine learning is putting a doctor in your pocket
-
1:02
role of hypomethylating agents in the novel agent era
-
4:28
predicting prognosis in myelodysplastic syndromes
-
1:50
hypomethylating agent based combinations in mds
-
3:44
novel agents for mds on the basis of understanding disease biology
-
1:05:17
no doctor needed? dr. michael abramoff on the potential of autonomous ai